Search Orphan Drug Designations and Approvals
-
Generic Name: | Follistatin291-IgG2 Fc fusion protein |
---|---|
Date Designated: | 07/03/2018 |
Orphan Designation: | Treatment of facioscapulohumeral muscular dystrophy |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 10/04/2019 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Acceleron Pharma Inc. 128 Sidney Street Cambridge, Massachusetts 02139 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-